Hepatitis C in pregnancy: an observational study highlighting its association with maternal parameters


  • Bushra . Department of Gynecology, Liaquat University of Medical and Health Sciences, Jamshoro, Hyderabad, Pakistan
  • Ambreen Ghori Department of Gynecology, Liaquat University of Medical and Health Sciences, Jamshoro, Hyderabad, Pakistan
  • Azra Ahmed Department of Gynecology and Obstetrics, Suleman Roshan Medical College, Tando Adam, Pakistan
  • Najma Dalwani Department of Gynecology and Obstetrics, Indus Hospital, Badin, Pakistan
  • Mushtaque Ali Shah Department of Paediatrics, Liaquat University of Medical and Health Sciences, Jamshoro, Hyderabad, Pakistan
  • Madiha Ariff Student, DUHS, Karachi, Pakistan




Hepatitis C, Maternal variables, Pregnant woman


Background: Pregnancy is a very crucial time in a woman’s life. In this period of time, not only multiple physiological alterations effect the usual health status but also makes women more vulnerable to contract infection and face negative sequalae. Hepatitis C, a blood borne viral infection serve the similar fate when encountered by pregnant ladies. This study is based on exploring the prevalence of the Hepatitis C virus seropositivity among pregnant population. Moreover, we also evaluated the major risk factors leading to the infection in these mothers. Besides this, infected mothers were studied for their pregnancy outcomes.

Methods: In this study 114 pregnant females were observed for this cross-sectional study. It was conducted in Gynecology Unit- 1, Liaquat University Hospital Hyderabad, for the period of January 2017 to July 2017. Chi square test was applied for statistical analysis on SPSS version 16. The criteria for enrollment in the study was set to be a pregnant lady belonging to age group 20-35 years; having singleton pregnancy; was a booked case at the hospital with compliant to antenatal follow ups; admitted to the labor room for delivery. All the non-pregnant ladies, whom had co morbid conditions such as hypertension or diabetes or had infected with hepatitis B or D were excluded from the study. Furthermore, pregnant ladies with multiple gestion or those who were either diagnosed of hepatitis C prior to conceive or had a previous history of hepatitis C were also excluded.

Results: Present study revealed that out of 114, 10(8.8%) pregnant ladies were found seropositive for Hepatitis C virus. Prior history for transfusion of blood was the Foremost risk factor discovered, with 60.5% women reported this. History of surgery was the 2nd commonest factor and 43.9% had this in their medical records. On the other hand, only 8.8% women gave the history for previous evacuation. While observing pregnancy outcomes, we found 48.2% neonates had low birth weight, 41.2% were born preterm and 21.1% had low APGAR score.

Conclusions: In a nutshell hepatitis c is prevalent in the pregnant population of this region and showing its effects in the form of compromised pregnancies. History of blood transfusion and previous surgery were found to be chief risk factors in the study.


Kushner T, Terrault NA. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care. Hepatol Commun. 2019 Jan;3(1):20-8.

World Health Organization. Global hepatitis report 2017: web annex A: estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2017. World Health Organization; 2018.

Zucker J, Aaron JG, Feller DJ, Slowikowski J, Evans H, Scherer ML, et al. Development and validation of an electronic medical record–based algorithm to identify patient milestones in the Hepatitis C virus care cascade. In Open Forum Inf Dis. 2018 Jul 3;5(7):153.

Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of Felege Hiwot Referral Hospital, northwest Ethiopia: a cross-sectional study. Virol J. 2015 Dec;12(1):204.

World Health Organization. Hepatitis C: Factsheet No. 164. 2015. Available at: http://www.who.int/topics/hepatitis/factsheets/en/. Accessed 10 August 2015.

Jadoon SM, Adeel M, Aslam S, Rasool A. Hepatitis B and Hepatitis C virus in women with first pregnancy. J Ayub Med Coll Abbottabad. 2017 Aug 20;29(4):614-8.

World Health Organization. Guidelines for the screening, care and treatment of persons with Hepatitis C infection. April 2014. Available at: http://apps.who.int.revproxy.brown.edu/iris/bitstream/10665/ 111747/1/9789241548755_eng.pdf?ua=1 Accessed on 20 February 2018.

Tovo PA, Calitri C, Scolfaro C, Gabiano C, Garazzino S. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. World J Gastroenterol. 2016 Jan 28;22(4):1382.

Hughes BL, Page CM, Kuller JA. Society for Maternal-Fetal Medicine (SMFM. Hepatitis C in pregnancy: screening, treatment, and management. Am J Obstetr Gynecol. 2017 Nov 1;217(5):B2-12.

Rinaldi L, Nascimbeni F, Giordano M, Masetti C, Guerrera B, Amelia A, et al. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World J Gastroenterol. 2017 Feb 28;23(8):1458.

Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016 Sep 10;388(10049):1081-8.

Tan EK, Tan EL. Alterations in physiology and anatomy during pregnancy. Best Pract Res Clinobstetr Gynaecol. 2013 Dec 1;27(6):791-802.

Kia L, Rinella ME. Interpretation and management of hepatic abnormalities in pregnancy. Clin Gastroenterol Hepatol. 2013 Nov 1;11(11):1392-8.

Muñoz-Gámez JA, Salmeron J, Ruiz-Extremera A. Hepatitis C during pregnancy, vertical transmission and new treatment possibilities. Med Clíni. 2016 Dec 2;147(11):499-505.

Dibba P, Cholankeril R, Li AA, Patel M, Fayek M, Dibble C, et al. Hepatitis C in pregnancy. Dis. 2018;6(2):E31.

Spera AM, Eldin TK, Tosone G, Orlando R. Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?. World J Hepatol. 2016 Apr 28;8(12):557.

Centers for Disease Control and Prevention. Hepatitis C FAQs for Health Professionals; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2018. Available at: www.cdc.gov/globalhealth/countries/georgia/default.htm. Accessed 9 May 2019.

American Association for the Study of Liver Diseases, & Infectious Diseases Society of America. Recommendations for Testing, Managing, and Treating Hepatitis C. 2018. Available at: http://www. hcvguidelines.org. Accessed 21 February 2018.

Jhaveri R, Broder T, Bhattacharya D, Peters MG, Kim AY, Jonas MM. Universal screening of pregnant women for hepatitis C: the time is now. Clin Inf Dis. 2018 Sep 12;67(10):1493-7.

Parent S, Salters K, Awendila L, Ti L. Hepatitis C and pregnancy outcomes: a systematic review protocol. BMJ Open. 2018;8:e024288.

Pott H Junior, Theodoro M, de Almeida Vespoli J, Senise JF, Castelo A. Mother-to-child transmission of hepatitis C virus. Eur J Obstet Gynecol Repro Biol. 2018;224:125-30.

Yang L, Zhao R, Zheng Y, Song X. Effect of hepatitis C virus infection on the outcomes of in vitro fertilization. Int J Clin Exper Med. 2015;8(4):6230.

Hanson BM, Dorais JA. Reproductive considerations in the setting of chronic viral illness. Am J Obstetr Gynecol. 2017 Jul 1;217(1):4-10.

Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Inf Dis. 2014 Jun 13;59(6):765-73.

Pawlowska M. Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children. Expert Opin Drug Saf. 2015;14(3):343-8.

Al-Kubaisy W, Daud S, Al-Kubaisi MW, Al-Kubaisi OW, Abdullah NN. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad. J Maternal-Fetal Neonatal Med. 2019 Oct 18;32(20):3464-9.

Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, et al. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. J Hepatol. 2018;68(4):867.

Esmaeili A, Mirzazadeh A, Carter GM, Esmaeili A, Hajarizadeh B, Sacks HS, et al. Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta‐analysis. J Viral Hepat. 2017 Feb;24(2):117-27.

Ly KN, Jiles RB, Teshale EH, Foster MA, Pesano RL, Holmberg SD. Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014. Annal Inter Med. 2017 Jun 6;166(11):775-82.

Afsheen Z, Ahmad B, Linfang H. Prevalence of Hepatitis C and associated risk factors among pregnant women of district Nowshera, Khyber Pakhtunkhwa. Adv life sci. 2018;5(4):166-70.

Afsheen Z, Ahmad B, Linfang H. Prevalence of Hepatitis C and associated risk factors among pregnant women of district Nowshera, Khyber Pakhtunkhwa. Advance Life Sci. 2018 Aug 25;5(4):166-70.

Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of hepatitis B and C viral infections among pregnant women. North Am J Med Sci. 2011 May;3(5):238.

Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana’a, Yemen. BMC Preg Childbirth. 2013;13:127.

Patrick SW, Bauer AM, Warren MD, Jones TF, Wester C. Hepatitis C virus infection among women giving birth-Tennessee and United States, 2009-2014. MMWR. Morbid Mortal Weekly Report. 2017 May 12;66(18):470.

Floreani, A. Hepatitis C and pregnancy. World J. Gastroenterol. 2013;19:(40):6714-20.

Yeung LT, King SM, Roberts EA. Mother‐to‐infant transmission of hepatitis C virus. Hepatol. 2001 Aug;34(2):223-9.

Money D, Boucoiran I, Wagner E, Dobson S, Kennedy A, Lohn Z, et al. Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants. J Obstetr Gynaecol Canada. 2014 Sep 1;36(9):785-94.

Huang QT, Hang LL, Zhong M, Gao YF, Luo ML, Yu YH. Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies. Med. 2016 Aug;95(35).

Huang QT, Huang Q, Zhong M, Wei SS, Luo W, Li F, et al. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. J Viral Hepat. 2015;22(12):1033-42.

Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011 Sep;31(8):1163-70.




How to Cite

., B., Ghori, A., Ahmed, A., Dalwani, N., Shah, M. A., & Ariff, M. (2019). Hepatitis C in pregnancy: an observational study highlighting its association with maternal parameters. International Journal of Research in Medical Sciences, 8(1), 344–350. https://doi.org/10.18203/2320-6012.ijrms20195941



Original Research Articles